<DOC>
	<DOCNO>NCT02620410</DOCNO>
	<brief_summary>The RELAX-OAB ( Treatment REfractory Overactive BLadder AXonics Sacral Neuromodulation System ) post-market clinical follow-up ( PMCF ) study design confirm performance Axonics Sacral Neuromodulation ( SNM ) System aid treatment symptom overactive bladder ( OAB ) well capture patient satisfaction quality life data .</brief_summary>
	<brief_title>Treatment REfractory Overactive BLadder With AXonics Sacral Neuromodulation System</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>Diagnosis OAB demonstrate 3day void diary define ≥ 8 voids/day , and/or minimum 2 involuntary leak episode 72hour period Positive motor response least two implanted electrode intraoperative test Failed , candidate conservative treatment ( e.g. , pelvic floor training , biofeedback , behavioral modification , oral pharmacotherapy ) No change current regimen medication affect bladder function least 4 week prior begin baseline void diary Willing capable providing inform consent Capable participate test associate clinical investigation Primary stress incontinence mixed incontinence stress component override urgency component Current urinary tract mechanical obstruction benign prostatic enlargement urethral stricture Interstitial cystitis bladder pain syndrome define either AUA EAU guideline History pelvic cancer Any significant medical condition likely interfere study procedure , device operation , likely confound evaluation study endpoints Any psychiatric personality disorder discretion study physician PHQ9 Patient Depression Score ≥ 10 Current symptomatic urinary tract infection ( UTI ) 3 UTIs past year Any neurological condition may interfere normal bladder function , include stroke , multiple sclerosis , Parkinson 's disease , clinically significant peripheral neuropathy , spinal cord injury ( e.g. , paraplegia ) Severe uncontrolled diabetes ( A1C &gt; 8 , document last 3 month ) diabetes peripheral nerve involvement Treatment urinary symptom botulinum toxin therapy past 12 month Treatment urinary symptom tibial nerve stimulation past 3 month Previously implant sacral neuromodulation device participate sacral neuromodulation trial Subject document history allergic response titanium , zirconia , polyurethane , epoxy , silicone Knowledge plan MRIs , diathermy , high output ultrasonic exposure Any active implanted device include neurostimulators ( e.g. , cochlear implant , pacemaker ) and/or drug delivery pump , whether turned Passive implant ( e.g. , prosthesis ) allow , implanted metal Neurostimulator implant site A female breastfeeding childbearing potential positive urine pregnancy test use adequate contraception Participation current clinical trial within precede 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>OAB</keyword>
</DOC>